Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension

Completed · Phase 1

Conditions studied: Glaucoma and Ocular Hypertension

In brief

The purpose of this study is to determine the intraocular Pressure (IOP) lowering response and evaluate the safety of brimonidine tartrate 0.025% ophthalmic solution in adult subjects with open angle glaucoma or ocular hypertension.

Key facts

Study ID

NCT01687426

Run by

Eye Therapies, LLC

People needed

15

Starts

2012-09-01

Expected to finish

2012-12-01

Last updated by the study team

2012-12-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be at least 18 years of age at Visit 1 (Screening), of either sex and any race
• Be willing and able to provide written informed consent prior to any study procedures being performed.
• Be willing and able to follow all instructions and attend all study visits.
• Be willing to discontinue use of disallowed medication
• Have a documented diagnosis of ocular hypertension, open angle glaucoma or chronic angle closure glaucoma with a patent iridotomy.

You may not qualify if…

• Have known sensitivity or poor tolerance to brimonidine or any other component of the study medications.
• Have any form of glaucoma other than open-angle glaucoma, ocular hypertension or chronic angle closure glaucoma with patent iridotomy.

Where it is running

• Clinical Site — Winchester, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.